✦ LIBER ✦

Corrigendum to “Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 non small cell lung cancer (NSCLC)” [Lung Cancer 18 (S1) (1997) 160]

✍ Scribed by Komaki, R.; Milas, L.; Fujii, T.; Jay, Ro; Alan, P.; El-Naggar, A.K.; Mountain, C.; Ordonez, N.G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

624 Tumor biomarkers in lung cancer: An

✍ Komaki, R.; Milas, L.; Fujii, T.; Jay, Ro; Alan, P.; Perkins, P.; El-Naggar, A.K 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Corrigendum to “Effectiveness of bevaciz

✍ Nuijten, Mark; Heigener, David F.; Bischoff, Helge G.; Chouaid, Christos; Vergne 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Corrigendum to “Effectiveness of bevaciz

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 262 KB

P-539 Response to a combination of S-1 a

✍ Sugawara, Shunichi; Nakai, Yushi; Ichinose, Yukito; Yoshimori, Kozo; Sakai, Hiro 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

CK19 is superior to MUC1 as a marker of

✍ Thomas A Aloia; David H Harpole Jr.; Thomas A D’Amico 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Phase 1/2 trial of autologous tumor mixe

✍ Nemunaitis, J; Jahan, T; Ross, H; Sterman, D; Richards, D; Fox, B; Jablons, D; A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 170 KB